Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
Sponsor
Bausch Health Americas, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00366431
Collaborator
(none)
420
67
7
6.3
0.9
Study Details
Study Description
Brief Summary
The primary purpose of the protocol is to evaluate the safety, efficacy, and tolerability of MOA-728 in subjects with Opioid-Induced Bowel Dysfunction (OIBD) with associated chronic non-malignant pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Non-Malignant Pain
Study Start Date
:
Aug 1, 2006
Actual Study Completion Date
:
Mar 1, 2007
Outcome Measures
Primary Outcome Measures
- The effect of the interventional treatment will be measured by the change from baseline in the number of bowel movements per week during the double-blind treatment period. []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Adult outpatients with opioid-induced bowel dysfunction and chronic non-malignant pain.
-
Taking oral, transdermal, intravenous, or subcutaneous opioids.
-
Willingness to discontinue all pre-study laxative therapy and utilize only study permitted rescue laxatives.
Exclusion Criteria:
-
History of chronic constipation before the initiation of opioid therapy.
-
Other GI disorders known to affect bowel transit.
-
Women who are pregnant, breast-feeding, or plan to become pregnant.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Birmingham | Alabama | United States | 35215 | |
2 | Birmingham | Alabama | United States | 35244 | |
3 | Mobile | Alabama | United States | 36608 | |
4 | Phoenix | Arizona | United States | 85029 | |
5 | Tucson | Arizona | United States | 85710 | |
6 | Tucson | Arizona | United States | 85712 | |
7 | Tucson | Arizona | United States | 85741 | |
8 | Hot Springs | Arkansas | United States | 71913 | |
9 | Anaheim | California | United States | 92801 | |
10 | Anaheim | California | United States | 92805 | |
11 | Bakersfield | California | United States | 93311 | |
12 | Foothill Ranch | California | United States | 92610 | |
13 | Garden Grove | California | United States | 92843 | |
14 | Los Gatos | California | United States | 95032 | |
15 | Orange | California | United States | 92869 | |
16 | Sacramento | California | United States | 95831 | |
17 | San Diego | California | United States | 92108 | |
18 | San Diego | California | United States | 92120 | |
19 | San Diego | California | United States | 92121 | |
20 | Trumbull | Connecticut | United States | 06611 | |
21 | Hollywood | Florida | United States | 33021 | |
22 | Jacksonville | Florida | United States | 32216 | |
23 | Jupiter | Florida | United States | 33458 | |
24 | Largo | Florida | United States | 33770 | |
25 | Miami | Florida | United States | 33173 | |
26 | Miami | Florida | United States | 33180 | |
27 | Ocala | Florida | United States | 34471 | |
28 | Ormond Beach | Florida | United States | 32174 | |
29 | Saint Cloud | Florida | United States | 34769 | |
30 | Tampa | Florida | United States | 33607 | |
31 | West Palm Beach | Florida | United States | 33401 | |
32 | Dawsonville | Georgia | United States | 30534 | |
33 | Marietta | Georgia | United States | 30060 | |
34 | Marietta | Georgia | United States | 30066 | |
35 | Bloomington | Illinois | United States | 61701 | |
36 | Chicago | Illinois | United States | 60610 | |
37 | Indianapolis | Indiana | United States | 46250 | |
38 | Elkridge | Maryland | United States | 21075 | |
39 | Boston | Massachusetts | United States | 02115 | |
40 | Brockton | Massachusetts | United States | 02301 | |
41 | Saginaw | Michigan | United States | 48602 | |
42 | Traverse City | Michigan | United States | 49684 | |
43 | Picayune | Mississippi | United States | 39466 | |
44 | Independence | Missouri | United States | 64055 | |
45 | Missoula | Montana | United States | 59808 | |
46 | Omaha | Nebraska | United States | 68114 | |
47 | Reno | Nevada | United States | 89502 | |
48 | Haddon Heights | New Jersey | United States | 08035 | |
49 | Albuquerque | New Mexico | United States | 87102 | |
50 | Great Neck | New York | United States | 11023 | |
51 | Lake Success | New York | United States | 11042 | |
52 | Charlotte | North Carolina | United States | 28210 | |
53 | Winston-Salem | North Carolina | United States | 27103 | |
54 | Cincinnati | Ohio | United States | 45219 | |
55 | Cincinnati | Ohio | United States | 45224 | |
56 | Dayton | Ohio | United States | 45439 | |
57 | Clinton | Oklahoma | United States | 73601 | |
58 | Chattanooga | Tennessee | United States | 37404 | |
59 | Beaumont | Texas | United States | 77701 | |
60 | Colleyville | Texas | United States | 76034 | |
61 | San Antonio | Texas | United States | 78205 | |
62 | San Antonio | Texas | United States | 78209 | |
63 | San Antonio | Texas | United States | 78238 | |
64 | Alexandria | Virginia | United States | 22304 | |
65 | Christiansburg | Virginia | United States | 24073 | |
66 | Norfolk | Virginia | United States | 23502 | |
67 | Richmond | Virginia | United States | 23229 |
Sponsors and Collaborators
- Bausch Health Americas, Inc.
Investigators
- Study Director: Jeff Cohn, Bausch Health Americas, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00366431
Other Study ID Numbers:
- 3200A3-200
First Posted:
Aug 21, 2006
Last Update Posted:
Nov 25, 2019
Last Verified:
Nov 1, 2019
Keywords provided by ,
,
Additional relevant MeSH terms: